Neuphoria Therapeutics

NEUP · NASDAQ

$3.39+$0.08 (+2.42%)TodayMarket closed · Oct 20, 4:00 PM ET

Prev close $3.31

Latest news

Press releaseAug 4, 4:40 PM ETPRNewswire
Are CBZ, SAFT, NEUP, TCBK Obtaining Fair Deals for their Shareholders?
Press releaseJul 29, 10:36 PM ETPRNewswire
Are CBZ, SAFT, NEUP Obtaining Fair Deals for their Shareholders?
Press releaseJul 29, 1:42 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--UTZ, NEUP, SAFT, and NRIM
Press releaseJul 24, 1:50 PM ETBusiness Wire
NEUP Stock Alert: Halper Sadeh LLC is Investigating Whether Neuphoria Therapeutics Inc. is Obtaining a Fair Price for its Shareholders
Press releaseJul 24, 1:08 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Neuphoria Therapeutics, Inc. (NASDAQ: NEUP)
NewsJul 23, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsJul 23, 6:16 AM ET
Neuphoria Therapeutics To Be Acquired By Scancell In All-Share Deal; Combined Company To Seek $89M In Debt And Equity Financing Upon U.S. Listing
Press releaseJul 23, 6:11 AM ETGlobe Newswire
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
Press releaseJun 26, 4:15 PM ETGlobe Newswire
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
NewsMay 15, 2:44 PM ETCaroline Ryan
Deal Dispatch: GoPro Retains Houlihan Lokey In Strategic Review, Brookfield Buys World Freight Company, YesCare Corp. Bankruptcy
NewsMay 15, 9:23 AM ET
Neuphoria Therapeutics Q3 EPS $(0.09) Beats $(0.97) Estimate
Press releaseDec 8, 8:00 AM ETGlobe Newswire
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria's Director Nominees
Press releaseDec 4, 8:00 AM ETGlobe Newswire
Neuphoria Responds to Lynx1's Revised Indication of Interest at a Reduced Price and Premium
Press releaseDec 1, 8:00 AM ETGlobe Newswire
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
Press releaseNov 24, 8:00 AM ETGlobe Newswire
Neuphoria Therapeutics Inc. Sends Letter to Stockholders
Press releaseNov 11, 7:00 AM ETGlobe Newswire
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value
Press releaseOct 27, 4:29 PM ETGlobe Newswire
Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process
NewsOct 24, 10:09 AM ETAvi Kapoor
Nasdaq Surges 1%; Procter & Gamble Posts Upbeat Earnings
NewsOct 21, 1:06 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsOct 21, 9:50 AM ETAvi Kapoor
US Stocks Mixed; Coca-Cola Posts Upbeat Earnings
NewsOct 21, 8:16 AM ETAvi Kapoor
PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
NewsOct 21, 5:46 AM ETAvi Kapoor
Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Press releaseOct 20, 4:15 PM ETGlobe Newswire
Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder
Press releaseSep 29, 4:54 PM ETGlobe Newswire
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates
NewsSep 23, 1:06 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
Press releaseSep 4, 7:00 AM ETGlobe Newswire
Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD)
NewsAug 27, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
Press releaseMay 27, 4:10 PM ETGlobe Newswire
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
Press releaseMay 20, 4:22 PM ETGlobe Newswire
Neuphoria Provides First Quarter 2025 Business Updates
Press releaseApr 15, 8:00 AM ETGlobe Newswire
Neuphoria Provides a Review of 2024 and Highlights 2025 Plans
Press releaseMar 3, 7:30 AM ETGlobe Newswire
Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025
Press releaseFeb 12, 7:00 AM ETGlobe Newswire
Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck
NewsDec 26, 2:36 PM ETAvi Kapoor
S&P 500 Edges Lower, SciSparc Shares Surge
NewsDec 26, 1:50 PM ETAvi Kapoor
Dow Gains 50 Points, SEALSQ Shares Rally (CORRECTED)
NewsDec 26, 10:07 AM ETAvi Kapoor
Nasdaq Dips Over 100 Points, US Initial Jobless Claims Fall
Press releaseDec 23, 4:49 PM ETGlobe Newswire
Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Are CBZ, SAFT, NEUP, TCBK Obtaining Fair Deals for their Shareholders?

Are CBZ, SAFT, NEUP Obtaining Fair Deals for their Shareholders?

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--UTZ, NEUP, SAFT, and NRIM

NEUP Stock Alert: Halper Sadeh LLC is Investigating Whether Neuphoria Therapeutics Inc. is Obtaining a Fair Price for its Shareholders

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Neuphoria Therapeutics, Inc. (NASDAQ: NEUP)

12 Health Care Stocks Moving In Thursday's Intraday Session

Neuphoria Therapeutics To Be Acquired By Scancell In All-Share Deal; Combined Company To Seek $89M In Debt And Equity Financing Upon U.S. Listing

Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing

Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc

Deal Dispatch: GoPro Retains Houlihan Lokey In Strategic Review, Brookfield Buys World Freight Company, YesCare Corp. Bankruptcy

Neuphoria Therapeutics Q3 EPS $(0.09) Beats $(0.97) Estimate

Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria's Director Nominees

Neuphoria Responds to Lynx1's Revised Indication of Interest at a Reduced Price and Premium

Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions

Neuphoria Therapeutics Inc. Sends Letter to Stockholders

Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value

Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process

Nasdaq Surges 1%; Procter & Gamble Posts Upbeat Earnings

12 Health Care Stocks Moving In Tuesday's Intraday Session

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings

PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder

Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates

12 Health Care Stocks Moving In Tuesday's Intraday Session

Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD)

12 Health Care Stocks Moving In Wednesday's Intraday Session

Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting

Neuphoria Provides First Quarter 2025 Business Updates

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck

S&P 500 Edges Lower, SciSparc Shares Surge

Dow Gains 50 Points, SEALSQ Shares Rally (CORRECTED)

Nasdaq Dips Over 100 Points, US Initial Jobless Claims Fall

Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq